5 Health Services Stocks Nudging The Industry Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 20 points (0.1%) at 14,984 as of Friday, Aug. 23, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,794 issues advancing vs. 1,149 declining with 104 unchanged.

The Health Services industry currently sits up 0.1% versus the S&P 500, which is up 0.2%. Top gainers within the industry include Universal Health Services ( UHS), up 1.4%, and UnitedHealth Group ( UNH), up 0.9%.

TheStreet would like to highlight 5 stocks pushing the industry higher today:

5. DaVita HealthCare Partners ( DVA) is one of the companies pushing the Health Services industry higher today. As of noon trading, DaVita HealthCare Partners is up $0.67 (0.6%) to $110.64 on light volume. Thus far, 277,596 shares of DaVita HealthCare Partners exchanged hands as compared to its average daily volume of 868,600 shares. The stock has ranged in price between $109.80-$110.94 after having opened the day at $110.34 as compared to the previous trading day's close of $109.97.

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. DaVita HealthCare Partners has a market cap of $11.7 billion and is part of the health care sector. Shares are down 0.0% year to date as of the close of trading on Thursday. Currently there are 7 analysts that rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates DaVita HealthCare Partners as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, growth in earnings per share, increase in net income, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full DaVita HealthCare Partners Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

4. As of noon trading, Catamaran ( CTRX) is up $0.41 (0.7%) to $56.05 on light volume. Thus far, 303,930 shares of Catamaran exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $55.46-$56.11 after having opened the day at $55.65 as compared to the previous trading day's close of $55.64.

Catamaran Corporation provides pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefits management industry in North America. The company operates in two segments: PBM and HCIT. Catamaran has a market cap of $11.4 billion and is part of the health care sector. Shares are up 17.0% year to date as of the close of trading on Thursday. Currently there are 14 analysts that rate Catamaran a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates Catamaran as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, compelling growth in net income and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Catamaran Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading, Humana ( HUM) is up $0.80 (0.9%) to $94.28 on light volume. Thus far, 298,249 shares of Humana exchanged hands as compared to its average daily volume of 1.2 million shares. The stock has ranged in price between $93.45-$94.58 after having opened the day at $93.93 as compared to the previous trading day's close of $93.48.

Humana Inc., a health care company, offers a range of insurance products, and health and wellness services that incorporate an integrated approach to lifelong well-being. The company operates in three segments: Retail, Employer Group, and Healthcare Services. Humana has a market cap of $14.3 billion and is part of the health care sector. Shares are up 33.3% year to date as of the close of trading on Thursday. Currently there are 11 analysts that rate Humana a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Humana as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, attractive valuation levels and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Humana Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Aetna ( AET) is up $0.88 (1.4%) to $64.58 on average volume. Thus far, 1.3 million shares of Aetna exchanged hands as compared to its average daily volume of 2.8 million shares. The stock has ranged in price between $63.72-$64.62 after having opened the day at $63.91 as compared to the previous trading day's close of $63.70.

Aetna Inc. operates as a diversified health care benefits company in the United States. The company operates in three segments: Health Care, Group Insurance, and Large Case Pensions. Aetna has a market cap of $23.4 billion and is part of the health care sector. Shares are up 37.6% year to date as of the close of trading on Thursday. Currently there are 11 analysts that rate Aetna a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Aetna as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, increase in net income, attractive valuation levels and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Aetna Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, Baxter International ( BAX) is up $0.46 (0.6%) to $71.88 on light volume. Thus far, 941,276 shares of Baxter International exchanged hands as compared to its average daily volume of 2.8 million shares. The stock has ranged in price between $71.44-$72.09 after having opened the day at $71.51 as compared to the previous trading day's close of $71.42.

Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $38.6 billion and is part of the health care sector. Shares are up 7.1% year to date as of the close of trading on Thursday. Currently there are 12 analysts that rate Baxter International a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins, solid stock price performance and notable return on equity. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Baxter International Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).
null